A-93178

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameA-93178
Drug Alias NameA-93178.5A-93178
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action5-lipoxygenase activating protein modulators
Targets5-lipoxygenase activating protein
Therapy Area/IndicationsInflammationHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A